A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Protein kinases play a pivotal role in cell signaling, and dysregulation of many kinases has been linked to disease development. A large number of kinase inhibitors are therefore currently under investigation in clinical trials, and so far seven inhibitors have been approved as anti-cancer drugs. In...
Autors principals: | Fedorov, O, Marsden, B, Pogacic, V, Rellos, P, Müller, S, Bullock, A, Schwaller, J, Sundström, M, Knapp, S |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2007
|
Ítems similars
-
FIKK Kinase, a Ser/Thr Kinase Important to Malaria Parasites, Is Inhibited by Tyrosine Kinase Inhibitors
per: Benjamin C. Lin, et al.
Publicat: (2017-10-01) -
Insights for the development of specific kinase inhibitors by targeted structural genomics.
per: Fedorov, O, et al.
Publicat: (2007) -
Natural Compounds and Derivatives as Ser/Thr Protein Kinase Modulators and Inhibitors
per: Barbara Guerra, et al.
Publicat: (2019-01-01) -
Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity.
per: Pogacic, V, et al.
Publicat: (2007) -
Substrate Specificity of Recombinant Ser/Thr Protein Kinase
per: Anna Zorina, et al.
Publicat: (2015-03-01)